ISPO

Hormonal Cofactors

Do difference in sensitivity to estrogen and dopamine predispose certain lactotroph populations to adenoma formation?

B Velkeniers, M Kazemzadeh, L Vanhaelst, EL Hooghe-Peters

Oestrogen replacement therapy and risk for breast cancer

H Olsson MD PhD, J Ranstam PhD

Socioeconomic factors as predictors of estrogen receptor status in primary breast cancer tumors

NH Gordon, PhD, JP Crowe, MD, NA Berger, MD

Preliminary evaluation of a gonadotropin hormone agonist & sex-steroids to prevent breast cancer

D Spicer MD, M Pike PhD

Tamoxifen and ZK 119010 exert mixed agonistic and anta- gonistic effects on PS2 expression in MCF-7 cells

G Vollmer PhD, N Schutze PhD, MR Schneider PhD, R Knuppen PhD

Effects of growth hormone and cancer on glucose metabolism

M, Torosian MD, D, Bartlett, MD

A notionally simple but controversial way to prevent breast cancer

TGC Murrell

Interaction between antiestrogens and calmodulin

A Fanidi, Y Guichard, JM Fayard, JF Pageaux, C Laugier

Effect of the anti-androgen ICI 176,334 on prostatic cell growth

R Casano, A Comerci, C Selli, M Rizzo, G Forti, G. Fiorelli

Effect of "alcohol" ingestion on "carcinogenesis" by synthetic estrogen and progestin in the rat liver

K Yamagiwa MD, R Mizumoto MD, S Higashi MD, T Tomida MD, S Uehara MD, K Tanigawa MD, M Tanaka MD, N Ishida MD

Growth hormone(GH) has different effects than insulin-like growth factor (IGF-I) on liver cells in vitro: a morphological study

G Vergani, A Mayerhofer, A Bartke